Search research articles
Contact Us
Filters
Showing results (161-170 of 177) with videos related to
Page
of 18
Sort By:
Cancer Research
|
May 1, 1993
p53 mutation is a common genetic event in ovarian carcinoma
B J Milner, L A Allan, D M Eccles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1987
Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breast
R C Leonard, M A Cornbleet, S B Kaye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1994
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial
G C Wishart, D Bissett, J Paul, et al.
Cancer Treatment Reports
|
November 1, 1984
Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies
K C Anderson, A T Skarin, D S Rosenthal, et al.
BMJ (Clinical Research Ed.)
|
December 7, 1991
Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?
J F Smyth, R E Coleman, M Nicolson, et al.
European Journal of Cancer & Clinical Oncology
|
July 1, 1985
cis-Platinum and vindesine in combination in the treatment of non-small cell lung cancer
J Carmichael, A Gregor, M A Cornbleet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1995
Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer
H Gabra, S P Langdon, J E Watson, et al.
British Journal of Cancer
|
July 1, 1994
Can long-term survival be improved in patients with small-cell lung cancer (SCLC) and good performance status? Medical Research Council Lung Cancer Working Party
N M Bleehen, D J Girling, A Gregor, et al.
British Journal of Cancer
|
October 1, 1991
A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party
N M Bleehen, D J Girling, A Gregor, et al.
Cancer Research
|
November 1, 1988
Characterization and properties of nine human ovarian adenocarcinoma cell lines
S P Langdon, S S Lawrie, F G Hay, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 177) with videos related to
Sort By:
Page
of 18
Cancer Research
|
May 1, 1993
p53 mutation is a common genetic event in ovarian carcinoma
B J Milner, L A Allan, D M Eccles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1987
Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breast
R C Leonard, M A Cornbleet, S B Kaye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1994
Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial
G C Wishart, D Bissett, J Paul, et al.
Cancer Treatment Reports
|
November 1, 1984
Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies
K C Anderson, A T Skarin, D S Rosenthal, et al.
BMJ (Clinical Research Ed.)
|
December 7, 1991
Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?
J F Smyth, R E Coleman, M Nicolson, et al.
European Journal of Cancer & Clinical Oncology
|
July 1, 1985
cis-Platinum and vindesine in combination in the treatment of non-small cell lung cancer
J Carmichael, A Gregor, M A Cornbleet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1995
Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer
H Gabra, S P Langdon, J E Watson, et al.
British Journal of Cancer
|
July 1, 1994
Can long-term survival be improved in patients with small-cell lung cancer (SCLC) and good performance status? Medical Research Council Lung Cancer Working Party
N M Bleehen, D J Girling, A Gregor, et al.
British Journal of Cancer
|
October 1, 1991
A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. The Medical Research Council Lung Cancer Working Party
N M Bleehen, D J Girling, A Gregor, et al.
Cancer Research
|
November 1, 1988
Characterization and properties of nine human ovarian adenocarcinoma cell lines
S P Langdon, S S Lawrie, F G Hay, et al.
Page
of 18